CALCRL (Q16602) variants and mutations
CALCRL (also known as Q16602) is a human protein-coding gene encoding a calcitonin gene-related peptide type 1 receptor protein. A G protein-coupled receptor whose ligand specificity is set by receptor activity-modifying proteins (RAMPs). With RAMP1 it forms the receptor for CGRP peptides, while with RAMP2 or RAMP3 it forms adrenomedullin receptors that activate cAMP signaling. This analysis covers 847 CALCRL variants and mutations. Of these, 83% have computational variant effect predictions. Disease context includes migraine disorder, hypertensive disorder, and lymphatic malformation 8. Example CALCRL variants include M1?, E2K, and K4*.
Variant analysis overview
- Gene: CALCRL
- Protein: Q16602
- UniProt accession: Q16602
- Organism: Homo sapiens
- Variants analyzed: 847
- Variant scope: all variants
- Completed: 2026-07-23
Variant and mutation evidence
- Variant composition: 593 unspecified-consequence records; 3 stop lost; 1 stop retained variant; 132 missense variants; 89 synonymous variants; 3 in-frame deletions; 16 frameshift variants; 1 in-frame insertions; 5 stop-gained variants; 4 splice-region variants
- Prediction scores: 701 variants have prediction scores (83% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: migraine disorder, hypertensive disorder, lymphatic malformation 8, essential hypertension, Non-immune hydrops fetalis, obesity disorder, hyperprolactinemia, Increased circulating prolactin concentration, coronary artery disorder, venous thromboembolism, cardiovascular disorder, overnutrition.
Protein structure and variant hotspots
- Protein features: 7 transmembrane segments; 5 post-translational modification sites.
- Structural context: 306 variants have structural context.
- PTM context: 14 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable CALCRL variants
Examples include M1?, E2K, K4*, K4M, K4R, C5Y, T6A, T6I. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, cosmic curated COSV66475, NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- E2K (p.Glu2Lys), cosmic curated COSV66474, TOPMed rs879841583, gnomAD rs879841583, REVEL 0.06, CADD 17.60
- K4* (p.Lys4Ter), cosmic curated COSV66473
- K4M (p.Lys4Met), NCI-TCGA Cosmic COSV6647, MetaLR 0.07, MetaSVM -1.07, Variant assessed as somatic; moderate impact.
- K4R (p.Lys4Arg), NCI-TCGA Cosmic COSV6647, cosmic curated COSV66476, REVEL 0.05, CADD 2.79, Variant assessed as somatic; moderate impact.
- C5Y (p.Cys5Tyr), 1000Genomes rs201472047, ExAC rs201472047, TOPMed rs201472047, gnomAD rs201472047, REVEL 0.04, CADD 0.00
- T6A (p.Thr6Ala), gnomAD rs1286832300, REVEL 0.03, CADD 0.01
- T6I (p.Thr6Ile), rs780410767, NCI-TCGA Cosmic COSV6647, cosmic curated COSV66477, REVEL 0.02, CADD 0.28, Variant assessed as somatic; moderate impact.
- T6N (p.Thr6Asn), NCI-TCGA Cosmic COSV6647, cosmic curated COSV66476, REVEL 0.01, CADD 0.88, Variant assessed as somatic; moderate impact.
- L7Q (p.Leu7Gln), cosmic curated COSV66474, REVEL 0.12, CADD 12.40
- L7V (p.Leu7Val), Ensembl rs1688172230
- Y8C (p.Tyr8Cys), TOPMed rs1341495595, gnomAD rs1341495595, REVEL 0.02, CADD 6.44
- Y8D (p.Tyr8Asp), 1000Genomes rs698577, ESP rs698577, ExAC rs698577, TOPMed rs698577
- Y8H (p.Tyr8His), 1000Genomes rs698577, ESP rs698577, ExAC rs698577, TOPMed rs698577, CADD 4.85, PolyPhen-2 0.00
- Y8N (p.Tyr8Asn), rs698577, UniProt VAR 054822, 1000Genomes rs698577, ESP rs698577, CADD 6.57, PolyPhen-2 0.01
- F9Y (p.Phe9Tyr), gnomAD rs1688171679, REVEL 0.12, CADD 20.80
- V11L (p.Val11Leu), TOPMed rs1274469006, gnomAD rs1274469006, REVEL 0.06, CADD 0.15
- L12I (p.Leu12Ile), NCI-TCGA Cosmic COSV6647, cosmic curated COSV66475, REVEL 0.03, CADD 6.99, Variant assessed as somatic; moderate impact.
- L12P (p.Leu12Pro), NCI-TCGA Cosmic COSV1011, cosmic curated COSV10113, REVEL 0.20, CADD 21.00, Variant assessed as somatic; moderate impact.
- L13M (p.Leu13Met), ExAC rs762445818, gnomAD rs762445818, REVEL 0.09, CADD 12.70
- P14L (p.Pro14Leu), cosmic curated COSV66476, REVEL 0.12, CADD 13.70
- P14S (p.Pro14Ser), TOPMed rs1464838331, gnomAD rs1464838331, REVEL 0.09, CADD 0.78
- F16L (p.Phe16Leu), rs13391909, UniProt VAR 049453, 1000Genomes rs13391909, ESP rs13391909, REVEL 0.02, CADD 1.40
- F16Y (p.Phe16Tyr), cosmic curated COSV10749, MetaLR 0.08, MetaSVM -0.99
- M17K (p.Met17Lys), TOPMed rs1433379180, gnomAD rs1433379180, REVEL 0.17, CADD 10.60
- M17T (p.Met17Thr), TOPMed rs1433379180, gnomAD rs1433379180, REVEL 0.10, CADD 8.59
- I18M (p.Ile18Met), Ensembl rs1688056188, MetaLR 0.06, MetaSVM -1.03
- L19I (p.Leu19Ile), NCI-TCGA Cosmic COSV6647, cosmic curated COSV66475, REVEL 0.04, CADD 16.10, Variant assessed as somatic; moderate impact.
- V20L (p.Val20Leu), ExAC rs758743722, gnomAD rs758743722, REVEL 0.06, CADD 11.40
- T21A (p.Thr21Ala), cosmic curated COSV66477, Ensembl rs2105785426
- T21I (p.Thr21Ile), rs751281594, ClinGen CA61841340, ClinVar RCV004158321, TOPMed rs751281594, REVEL 0.09, CADD 8.46, Likely benign, not specified
- T21K (p.Thr21Lys), cosmic curated COSV10443
- A22E (p.Ala22Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E23V (p.Glu23Val), TOPMed rs1688055358
- L24S (p.Leu24Ser), cosmic curated COSV66473
- E25K (p.Glu25Lys), NCI-TCGA Cosmic COSV6647, cosmic curated COSV66476, Variant assessed as somatic; moderate impact.
- E26D (p.Glu26Asp), rs2468705690, ClinGen CA349979033, ClinVar RCV004434517, Uncertain significance, not specified
- E26Q (p.Glu26Gln), gnomAD rs1326868810, REVEL 0.05, CADD 16.10
- S27N (p.Ser27Asn), ExAC rs779483045, gnomAD rs779483045, REVEL 0.02, CADD 0.24
- E29D (p.Glu29Asp), NCI-TCGA Cosmic COSV6647, cosmic curated COSV66475, REVEL 0.07, CADD 0.00, Variant assessed as somatic; moderate impact.
- E29K (p.Glu29Lys), cosmic curated COSV66476, TOPMed rs1289640533, gnomAD rs1289640533, REVEL 0.05, CADD 6.41
- E29Q (p.Glu29Gln), cosmic curated COSV10532, TOPMed rs1289640533, gnomAD rs1289640533, REVEL 0.03, CADD 1.53
- D30E (p.Asp30Glu), ExAC rs754406460, gnomAD rs754406460, REVEL 0.04, CADD 0.22
- D30N (p.Asp30Asn), NCI-TCGA Cosmic COSV6647, cosmic curated COSV66475, MetaLR 0.06, MetaSVM -1.01, Variant assessed as somatic; moderate impact.
- I32L (p.Ile32Leu), Ensembl rs2105785361, REVEL 0.05, CADD 1.11
- Q33* (p.Gln33Ter), cosmic curated COSV66474
- Q33H (p.Gln33His), cosmic curated COSV66473, TOPMed rs1053976961, gnomAD rs1053976961, REVEL 0.05, CADD 0.06
- L34F (p.Leu34Phe), cosmic curated COSV10113, REVEL 0.10, CADD 7.80
- G35R (p.Gly35Arg), NCI-TCGA Cosmic COSV1011, cosmic curated COSV10113, Variant assessed as somatic; moderate impact.
- T37A (p.Thr37Ala), TOPMed rs1688053741, gnomAD rs1688053741, REVEL 0.10, CADD 19.40
- T37N (p.Thr37Asn), cosmic curated COSV66478
- N39K (p.Asn39Lys), gnomAD rs1170205509
- N39Y (p.Asn39Tyr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- M42I (p.Met42Ile), cosmic curated COSV10823, TOPMed rs1377426721, gnomAD rs1377426721, REVEL 0.09, CADD 20.00
- M42L (p.Met42Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- T43A (p.Thr43Ala), ExAC rs764357347, TOPMed rs764357347, gnomAD rs764357347, REVEL 0.05, CADD 18.40
- A44G (p.Ala44Gly), cosmic curated COSV10470
- A44S (p.Ala44Ser), NCI-TCGA Cosmic COSV1011, cosmic curated COSV10113, Variant assessed as somatic; moderate impact.
- A44V (p.Ala44Val), TOPMed rs1688052585
- Q45* (p.Gln45Ter), cosmic curated COSV66474, CADD 37.00
- Q45E (p.Gln45Glu), NCI-TCGA Cosmic COSV6647, cosmic curated COSV66476, Ensembl rs1574255391, Variant assessed as somatic; moderate impact.
- Q45H (p.Gln45His), TOPMed rs1028403239, gnomAD rs1028403239, REVEL 0.36, CADD 18.00
- Y46* (p.Tyr46Ter), NCI-TCGA TCGA novel, CADD 35.00, Variant assessed as somatic; high impact.
- Y46C (p.Tyr46Cys), TOPMed rs1688051754
- Y46F (p.Tyr46Phe), NCI-TCGA TCGA novel, MetaLR 0.07, MetaSVM -1.08, Variant assessed as somatic; moderate impact.
- Y46H (p.Tyr46His), TOPMed rs995545514, gnomAD rs995545514, REVEL 0.17, CADD 23.00
- E47K (p.Glu47Lys), NCI-TCGA Cosmic COSV1011, cosmic curated COSV10113, Variant assessed as somatic; moderate impact.
- K51N (p.Lys51Asn), NCI-TCGA Cosmic COSV1011, cosmic curated COSV10113, REVEL 0.26, CADD 23.70, Variant assessed as somatic; moderate impact.
- I52F (p.Ile52Phe), ExAC rs751173685, gnomAD rs751173685, REVEL 0.20, CADD 26.40
- I52M (p.Ile52Met), ExAC rs765924388, gnomAD rs765924388, REVEL 0.19, CADD 12.40
- M53I (p.Met53Ile), ExAC rs762707664, TOPMed rs762707664, gnomAD rs762707664, cosmic curated COSV10113, REVEL 0.06, CADD 17.40
- M53R (p.Met53Arg), NCI-TCGA Cosmic COSV1011, cosmic curated COSV10113, MetaLR 0.12, MetaSVM -1.02, Variant assessed as somatic; moderate impact.
- M53T (p.Met53Thr), TOPMed rs936879860, REVEL 0.14, CADD 19.30
- M53V (p.Met53Val), gnomAD rs1199662856, REVEL 0.10, CADD 19.20
- D55G (p.Asp55Gly), cosmic curated COSV66474, REVEL 0.08, CADD 22.80
- D55Y (p.Asp55Tyr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P56H (p.Pro56His), cosmic curated COSV66478, REVEL 0.15, CADD 27.00
- P56S (p.Pro56Ser), 1000Genomes rs202148636, ExAC rs202148636, TOPMed rs202148636, gnomAD rs202148636, REVEL 0.10, CADD 22.30
- I57L (p.Ile57Leu), cosmic curated COSV66478, MetaLR 0.07, MetaSVM -1.04
- Q58E (p.Gln58Glu), TOPMed rs1179010202, gnomAD rs1179010202, REVEL 0.12, CADD 21.30
- Q59* (p.Gln59Ter), NCI-TCGA Cosmic COSV1011, cosmic curated COSV10113, Variant assessed as somatic; high impact.
- Q59K (p.Gln59Lys), Ensembl rs1688050255, REVEL 0.09, CADD 18.60
- A60E (p.Ala60Glu), cosmic curated COSV99061, REVEL 0.08, CADD 7.93
- A60P (p.Ala60Pro), NCI-TCGA Cosmic COSV6647, cosmic curated COSV66476, REVEL 0.05, CADD 9.27, Variant assessed as somatic; moderate impact.
- A60S (p.Ala60Ser), NCI-TCGA Cosmic COSV6647, MetaLR 0.04, MetaSVM -1.03, Variant assessed as somatic; moderate impact.
- A60V (p.Ala60Val), gnomAD rs1688050065, REVEL 0.04, CADD 14.60
- E61Q (p.Glu61Gln), TOPMed rs1254290668, gnomAD rs1254290668, REVEL 0.09, CADD 21.60
- G62D (p.Gly62Asp), rs751001936, ExAC rs751001936, TOPMed rs751001936, gnomAD rs751001936, AlphaMissense 0.14, MetaLR 0.42, Variant assessed as somatic; moderate impact.
- V63I (p.Val63Ile), rs757975393, ClinGen CA2020900, ClinVar RCV004434516, ExAC rs757975393, REVEL 0.07, CADD 3.27, Likely benign, not specified
- V63L (p.Val63Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Y64C (p.Tyr64Cys), Ensembl rs1687952522
- C65Y (p.Cys65Tyr), TOPMed rs1687952436
- R67K (p.Arg67Lys), cosmic curated COSV66477
- R67T (p.Arg67Thr), gnomAD rs1159828600, REVEL 0.52, CADD 26.70
- T68I (p.Thr68Ile), gnomAD rs1470241807, REVEL 0.44, CADD 27.70
- T68S (p.Thr68Ser), cosmic curated COSV10593
- W69L (p.Trp69Leu), cosmic curated COSV10113
- D70N (p.Asp70Asn), cosmic curated COSV66476
- G71A (p.Gly71Ala), gnomAD rs1384060779, REVEL 0.56, CADD 25.70
- G71R (p.Gly71Arg), ESP rs149634296
- W72* (p.Trp72Ter), Ensembl rs868756218, CADD 38.00
- W72R (p.Trp72Arg), Ensembl rs1687951893, REVEL 0.66, CADD 29.40
- N76K (p.Asn76Lys), ESP rs371195669, ExAC rs371195669, TOPMed rs371195669, gnomAD rs371195669
- D77E (p.Asp77Glu), TOPMed rs1687951319
- D77H (p.Asp77His), TOPMed rs1273852056, gnomAD rs1273852056, REVEL 0.41, CADD 24.40
- D77N (p.Asp77Asn), NCI-TCGA Cosmic COSV6647, cosmic curated COSV66475, TOPMed rs1273852056, gnomAD rs1273852056, REVEL 0.31, CADD 24.10, Variant assessed as somatic; moderate impact.
- D77Y (p.Asp77Tyr), TOPMed rs1273852056, gnomAD rs1273852056, REVEL 0.25, CADD 23.30
- V78A (p.Val78Ala), cosmic curated COSV66473, Ensembl rs1559052135, REVEL 0.10, CADD 21.20
- A79V (p.Ala79Val), rs1342504956, NCI-TCGA Cosmic COSV6647, cosmic curated COSV66475, TOPMed rs1342504956, AlphaMissense 0.09, MetaLR 0.15, Variant assessed as somatic; moderate impact.
- A80E (p.Ala80Glu), cosmic curated COSV10443
- A80T (p.Ala80Thr), TOPMed rs1687951005
- G81* (p.Gly81Ter), cosmic curated COSV66476
- G81E (p.Gly81Glu), ExAC rs761630558, gnomAD rs761630558, REVEL 0.83, CADD 25.30
- T82A (p.Thr82Ala), ESP rs150453265, ExAC rs150453265, TOPMed rs150453265, gnomAD rs150453265, REVEL 0.08, CADD 19.60
- T82I (p.Thr82Ile), TOPMed rs996080639, gnomAD rs996080639, REVEL 0.16, CADD 21.10
- T82S (p.Thr82Ser), TOPMed rs996080639, gnomAD rs996080639, REVEL 0.10, CADD 18.30
- E83* (p.Glu83Ter), cosmic curated COSV10470
- E83D (p.Glu83Asp), Ensembl rs1574252000, REVEL 0.09, CADD 1.17
- E83K (p.Glu83Lys), Ensembl rs2105780359
- S84L (p.Ser84Leu), cosmic curated COSV66474
- M85I (p.Met85Ile), TOPMed rs1313008625, gnomAD rs1313008625, REVEL 0.06, CADD 17.70
- M85T (p.Met85Thr), TOPMed rs1039696766, gnomAD rs1039696766, REVEL 0.06, CADD 19.30, Uncertain significance, not specified
- M85V (p.Met85Val), ESP rs139246267, ExAC rs139246267, TOPMed rs139246267, gnomAD rs139246267, REVEL 0.02, CADD 15.70
- Q86H (p.Gln86His), ExAC rs775415329, gnomAD rs775415329
- Q86K (p.Gln86Lys), NCI-TCGA Cosmic COSV6647, cosmic curated COSV66476, REVEL 0.20, CADD 22.60, Variant assessed as somatic; moderate impact.
- Q86L (p.Gln86Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L87F (p.Leu87Phe), cosmic curated COSV10823
- L87P (p.Leu87Pro), 1000Genomes rs61739909, ESP rs61739909, ExAC rs61739909, TOPMed rs61739909, REVEL 0.11, CADD 18.40
- P89H (p.Pro89His), cosmic curated COSV10113
- P89S (p.Pro89Ser), ExAC rs759762165, gnomAD rs759762165, REVEL 0.77, CADD 26.60
- D90A (p.Asp90Ala), cosmic curated COSV66476
- Y91H (p.Tyr91His), cosmic curated COSV66477
- Y91S (p.Tyr91Ser), Ensembl rs933504573
- F92L (p.Phe92Leu), NCI-TCGA Cosmic COSV6647, cosmic curated COSV66475, REVEL 0.48, CADD 26.40, Variant assessed as somatic; moderate impact.
- Q93H (p.Gln93His), cosmic curated COSV10113
- Q93K (p.Gln93Lys), cosmic curated COSV10470
- Q93R (p.Gln93Arg), Ensembl rs2105780304
- D94N (p.Asp94Asn), NCI-TCGA Cosmic COSV6647, cosmic curated COSV66477, Variant assessed as somatic; moderate impact.
- D96Y (p.Asp96Tyr), cosmic curated COSV66473
- P97L (p.Pro97Leu), rs974511157, NCI-TCGA Cosmic COSV6647, cosmic curated COSV66477, TOPMed rs974511157, REVEL 0.41, CADD 28.70, Variant assessed as somatic; moderate impact.
- P97Q (p.Pro97Gln), TOPMed rs974511157, REVEL 0.30, CADD 26.90
- S98L (p.Ser98Leu), TOPMed rs199799965, gnomAD rs199799965, REVEL 0.11, CADD 33.00
- S98T (p.Ser98Thr), rs374525357, cosmic curated COSV10113, ESP rs374525357, gnomAD rs374525357, REVEL 0.06, CADD 17.90, Variant assessed as somatic; moderate impact.
- K100E (p.Lys100Glu), Ensembl rs930133083
- K100T (p.Lys100Thr), TOPMed rs1687943270
- V101F (p.Val101Phe), Ensembl rs867211999
- V101G (p.Val101Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V101L (p.Val101Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- T102A (p.Thr102Ala), gnomAD rs1687943053, REVEL 0.33, CADD 23.50
- T102R (p.Thr102Arg), 1000Genomes rs527699745, REVEL 0.46, CADD 26.00
- K103R (p.Lys103Arg), TOPMed rs1574251628, MetaLR 0.49, MetaSVM 0.18
- C105F (p.Cys105Phe), cosmic curated COSV10749
- C105G (p.Cys105Gly), ExAC rs764002527, gnomAD rs764002527, REVEL 0.99, CADD 28.80
- C105S (p.Cys105Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D106G (p.Asp106Gly), NCI-TCGA Cosmic COSV6647, cosmic curated COSV66474, gnomAD rs1687942454, REVEL 0.12, CADD 22.70, Variant assessed as somatic; moderate impact.
- Q107E (p.Gln107Glu), ESP rs376650641, ExAC rs376650641, gnomAD rs376650641, REVEL 0.19, CADD 11.00
- Q107P (p.Gln107Pro), NCI-TCGA Cosmic COSV6647, cosmic curated COSV66476, REVEL 0.09, CADD 18.30, Variant assessed as somatic; moderate impact.
- D108E (p.Asp108Glu), TOPMed rs1687942026, gnomAD rs1687942026, REVEL 0.10, CADD 17.10, Uncertain significance, not specified
- D108H (p.Asp108His), gnomAD rs1408139222, REVEL 0.39, CADD 24.80
- G109E (p.Gly109Glu), Ensembl rs866787560
- F112L (p.Phe112Leu), gnomAD rs1421400911, REVEL 0.38, CADD 23.20
- H114Q (p.His114Gln), ExAC rs767449144, gnomAD rs767449144, REVEL 0.38, CADD 22.30
- A116E (p.Ala116Glu), gnomAD rs1201822877, REVEL 0.19, CADD 2.96
- A116T (p.Ala116Thr), gnomAD rs1266990120, REVEL 0.07, CADD 20.60
- S117C (p.Ser117Cys), NCI-TCGA Cosmic COSV6647, cosmic curated COSV66474, Variant assessed as somatic; moderate impact.
- S117I (p.Ser117Ile), cosmic curated COSV66476, MetaLR 0.23, MetaSVM -0.75
- W121* (p.Trp121Ter), cosmic curated COSV66474
- T122I (p.Thr122Ile), NCI-TCGA Cosmic COSV6647, cosmic curated COSV66477, MetaLR 0.45, MetaSVM -0.16, Variant assessed as somatic; moderate impact.
- N123H (p.Asn123His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N123I (p.Asn123Ile), cosmic curated COSV10470
- N123K (p.Asn123Lys), cosmic curated COSV10532, MetaLR 0.21, MetaSVM -0.84
- T125N (p.Thr125Asn), Ensembl rs2105779882, MetaLR 0.33, MetaSVM -0.37
- Q126K (p.Gln126Lys), cosmic curated COSV10593, NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Q126R (p.Gln126Arg), gnomAD rs1490548618, REVEL 0.03, CADD 10.10
- C127F (p.Cys127Phe), cosmic curated COSV66474
- C127S (p.Cys127Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V129D (p.Val129Asp), 1000Genomes rs72902462, REVEL 0.19, CADD 15.80
- V129I (p.Val129Ile), gnomAD rs1385126249, REVEL 0.05, CADD 14.10
- N130I (p.Asn130Ile), cosmic curated COSV66474
- N130K (p.Asn130Lys), cosmic curated COSV10113, REVEL 0.09, CADD 13.30
Public CALCRL analysis runs
- CALCRL analysis run — CALCRL (847 variants) — completed 2026-07-23